46 results
F-1/A
IINN
Inspira Technologies Oxy B.H.N. Ltd
20 May 24
Registration statement (foreign) (amended)
4:02pm
;
reasonable litigation expenses, including attorneys’ fees, expended by the office holder (a) as a result of an investigation or proceeding … instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (1) no indictment (as defined
F-1
IINN
Inspira Technologies Oxy B.H.N. Ltd
9 May 24
Registration statement (foreign)
5:02pm
of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (1) no indictment … (as defined in the Companies Law) was filed against such office holder as a result of such investigation or proceeding; and (2) no financial liability
F-1
EX-5.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
9 May 24
Registration statement (foreign)
5:02pm
than the laws of the State of Israel and have not, for the purpose of giving this opinion, made any investigation of the laws of any other jurisdiction
F-1
EX-4.7
IINN
Inspira Technologies Oxy B.H.N. Ltd
9 May 24
Registration statement (foreign)
5:02pm
.
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding … with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding the foregoing, nothing in this paragraph shall limit or restrict
6-K
EX-10.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Apr 24
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
8:46am
ascribed to such term in Section 3.1(hh).
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation … , an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.
“Prospectus” means the final base prospectus
6-K
EX-5.1
eaikt5
1 Apr 24
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
8:46am
S-8
EX-5.1
i6ba dhm1y5g
15 Mar 24
Registration of securities for employees
4:05pm
6-K
EX-10.1
z8wyuhd2cj08
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
6-K
EX-5.1
aal5iomb9
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
POS AM
cxsr44aa
10 Oct 23
Prospectus update (post-effective amendment)
5:00pm
6-K
EX-1.1
g5k00ppbfm 5wto
4 Apr 23
Report of Foreign Private Issuer
4:21pm
POS AM
3jhbdmt 2321btxlp
13 Oct 22
Prospectus update (post-effective amendment)
4:01pm
F-3
gvbbhqnvha1lk1z95i64
10 Aug 22
Shelf registration (foreign)
5:13pm
POS AM
d6vdoaqjeywhltm
14 Apr 22
Prospectus update (post-effective amendment)
4:40pm
20-F
9gf wy8cl
31 Mar 22
Annual report (foreign)
4:48pm
6-K
EX-99.1
3kgmybd7cztm irlm
20 Dec 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.1
tvcyz83hnq
30 Nov 21
Prof. Fan currently serves as the medical director of the extracorporeal life support program at the Toronto General Hospital
8:34am
6-K
EX-99.1
od4y739kq s8rv
12 Nov 21
Notice of EXTRAORDINARY General Meeting of shareholders
6:02am